Fisetin decreases the duration of ictal-like discharges in mouse hippocampal slices.
4AP
Brain slice
Fisetin
HCN channels
Molecular docking
Journal
Journal of biological physics
ISSN: 1573-0689
Titre abrégé: J Biol Phys
Pays: Netherlands
ID NLM: 0417731
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
06
04
2022
accepted:
27
07
2022
pubmed:
11
8
2022
medline:
30
8
2022
entrez:
10
8
2022
Statut:
ppublish
Résumé
There is an increasing interest in the biological and therapeutic effects of fisetin, a natural phenolic compound. Fisetin has affinity on some neuronal targets and may have the potential to modulate neuronal activity. In this study the effects of acute application of fisetin on synchronized events were evaluated electro-physiologically. Besides, interaction of fisetin with closely related channels were investigated in silico. Acute horizontal hippocampal slices were obtained from 32- to 36-day-old C57BL/6 mice. Extracellular field potentials were recorded from CA3 region of the hippocampus. Bath application of 4 aminopyridine (4AP, 100 µM) initiated ictal- and interictal-like synchronized epileptiform discharges in the brain slices. Fifty micromolar fisetin was applied to the recording chamber during the epileptiform activity. The duration and frequencies of both ictal-like and interictal-like activities were calculated from the electrophysiological records. Molecular docking was performed to reveal interaction of fisetin on GABA-A, NMDA, AMPA receptors, and HCN2 channel, which are neuronal structures directly involved in recorded activity. Although fisetin does not affect basal neuronal activity in brain slice, it reduced the duration of ictal-like discharges significantly. Molecular docking results indicated that fisetin has no effect on GABA-A, NMDA, and AMPA receptors. However, fisetin binds to the (5JON) HCN2 channel strongly with the binding energy of -7.66 kcal/mol. Reduction on the duration of 4AP-induced ictal-like discharges can be explained as HCN channels can cause an inhibitory effect via enhancing M-type K + channels which increase K outward currents.
Identifiants
pubmed: 35948819
doi: 10.1007/s10867-022-09612-0
pii: 10.1007/s10867-022-09612-0
pmc: PMC9411310
doi:
Substances chimiques
Flavonols
0
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
0
Receptors, AMPA
0
gamma-Aminobutyric Acid
56-12-2
N-Methylaspartate
6384-92-5
fisetin
OO2ABO9578
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
355-368Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Références
J Biol Chem. 2013 Nov 15;288(46):33136-45
pubmed: 24085296
RSC Adv. 2020 Jun 30;10(42):25046-25058
pubmed: 35517443
J Med Chem. 2021 Jan 28;64(2):1170-1179
pubmed: 33426889
Biomark Med. 2015;9(11):1225-39
pubmed: 26508561
J Med Chem. 2000 Dec 14;43(25):4759-67
pubmed: 11123984
Elife. 2016 Nov 18;5:
pubmed: 27858593
Molecules. 2018 Aug 21;23(9):
pubmed: 30134541
Epilepsy Res. 2019 Jul;153:49-58
pubmed: 30986657
Epilepsy Behav. 2015 Nov;52(Pt B):308-18
pubmed: 26074183
Biomedicines. 2022 Jun 19;10(6):
pubmed: 35740470
Front Chem. 2019 Oct 30;7:697
pubmed: 31750288
Am J Med. 2021 Jul;134(7):840-847
pubmed: 33775643
Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57
pubmed: 21534921
Pflugers Arch. 2020 Jul;472(7):931-951
pubmed: 32424620
Neurochem Res. 2021 Sep;46(9):2205-2225
pubmed: 34120291
Nature. 2018 Jul;559(7712):67-72
pubmed: 29950725
J Pharmacol Sci. 2018 Jan;136(1):42-45
pubmed: 29317180
Neurosci Lett. 2019 Jan 18;690:69-75
pubmed: 30316983
Neurobiol Dis. 2005 Jun-Jul;19(1-2):119-28
pubmed: 15837567
Biomed Phys Eng Express. 2021 Nov 10;8(1):
pubmed: 34724652
J Signal Transduct. 2012;2012:619747
pubmed: 22934165
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Nat Neurosci. 2009 May;12(5):577-84
pubmed: 19363490
Hippocampus. 2020 Oct;30(10):1112-1126
pubmed: 32543742
Acta Neurol Scand Suppl. 2013;(197):19-24
pubmed: 23480152
Expert Opin Pharmacother. 2017 Nov;18(16):1751-1764
pubmed: 29023170
Annu Rev Physiol. 2006;68:375-401
pubmed: 16460277
Annu Rev Physiol. 2003;65:453-80
pubmed: 12471170
J Biol Chem. 2012 Nov 23;287(48):40224-31
pubmed: 23038269
Food Sci Nutr. 2020 Nov 25;9(1):3-16
pubmed: 33473265
Neurochem Int. 2015 Oct;89:243-8
pubmed: 26271433
Antioxidants (Basel). 2020 Nov 11;9(11):
pubmed: 33187316
J Cheminform. 2012 Aug 13;4(1):17
pubmed: 22889332
Nutr Neurosci. 2017 May;20(4):255-264
pubmed: 27198489
Neurosci Lett. 2019 Jun 11;703:25-31
pubmed: 30880161
Eur J Pharmacol. 2021 Nov 5;910:174492
pubmed: 34516952
J Biol Chem. 1996 Apr 19;271(16):9603-11
pubmed: 8621635
Behav Brain Res. 2012 Mar 17;228(2):359-66
pubmed: 22197297